Drug discovery

#Artificial intelligence (AI) #Drug discovery #eBook #Imaging

eBook: The importance of imaging in drug discovery

Various imaging modalities are used throughout the process of drug discovery and development, both in the preclinical and clinical phases. According to analysts, Valuates, the global preclinical imaging market was valued at $1887.9 million in 2023 and is anticipated to reach $3021.2 million by 2030. Read More

#News

DDW Imaging eBook
#Artificial intelligence (AI) #Drug discovery #eBook #Imaging

The importance of imaging in drug discovery

This eBook, sponsored by Aurora Microplates, examines the role of imaging and its significance to the success of drug discovery and development. Download this exclusive eBook to learn more about: Two technological developments that have revolutionised the role of imaging in drug discovery The latest innovations in flow cytometry technology… Read More

#DDW eBooks #Intelligence

#Cardioprotection #Drug discovery #Drug safety #Drug toxicity #Whitepaper

Whitepaper: Transforming cardiac safety testing

Discover how VOLTA Scanner is transforming cardiac safety testing. This Whitepaper from Lumencor describes an optophysiology instrument, supporting stable, fast, high-resolution toxicity testing and drug development. Download to learn how: VOLTA detects early-after-depolarisations (EADs), and predicts QT/QRS risk Optogenetic pacing improves assay precision Automated, HPT optophysiological screening streamlines… Read More

#News

#Cardioprotection #Drug discovery #Drug safety #Drug toxicity

VOLTA Scanner illuminates cardiac safety testing

VOLTA Scanner is transforming cardiac safety testing. This whitepaper describes an optophysiology instrument, supporting stable, fast, high-resolution toxicity testing and drug development. Download to learn how: VOLTA detects early-after-depolarisations (EADs), and predicts QT/QRS risk Optogenetic pacing improves assay precision Automated, HPT optophysiological screening streamlines decisions… Read More

#Resources

#Career #Drug discovery #Interview #Meet the Researcher

Meet the researcher: Duncan McHale, Persica Pharmaceuticals

DDW’s Megan Thomas examines the work of Dr Duncan McHale, Chief Medical Officer at Persica Pharmaceuticals. MT: Can you tell us what you do and what you’re working on at the moment? DM:  In 2017, I founded an early drug development consultancy called Weatherden with Houman Ashrafian and Emma… Read More

#Exclusive Content

Cancer research
#Cancer research #Drug discovery #Events #Oncology #Webinar

Webinar: Where are the developments in cancer research?

This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. … Read More

Webinar date:
Sponsored by Scale Biosciences
#News

#Drug discovery

Ebook: The importance of imaging in drug discovery

As the demand for personalised medicine and targeted therapies grows, the need for customised imaging solutions in drug discovery becomes more pronounced. The rise in the use of automation and artificial intelligence is therefore having a significant impact on this market. This eBook, sponsored by Aurora Microplates, examines the… Read More

#DDW eBooks

#Biotechnology #Cardiometabolic diseases #Drug development #Drug discovery #ICON #Pharmaceuticals #Survey

More efficient next-gen obesity clinical trials needed, says survey

ICON has released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe, focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. Read More

#News

Neuroscience concept
#Drug discovery #Events #Neuroscience #Webinar

Webinar: Where is the opportunity in neuroscience drug discovery?

Hosted by Drug Discovery World and sponsored by Emulate, this webinar explores where innovation is taking place within neuroscience drug discovery.  The webinar sees experts and leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects… Read More

Webinar date:
Sponsored by Emulate
#News

Beacon Discovery Hero Image
#Cell analysis #DDW Tech Talks #Drug discovery

DDW Tech Talks with Bruker Cellular Analysis

In this new series, DDW Tech Talks explores how companies are utilising their products, services and technologies to advance drug discovery efforts. In this episode, we speak to Vikram Devgan VP of Global Marketing and Product Management, Bruker Cellular Analysis. Bruker has recently launched Beacon Discovery, a platform that enables… Read More

#News

Beacon Discovery Hero Image
#Cell sequencing #DDW Tech Talks #Drug discovery #Single-cell analysis

DDW Tech Talks with Bruker Cellular Analysis

In this DDW Tech Talks, Vikram Devgan, VP of Global Marketing and Product Management at Bruker Cellular Analysis introduces the company’s Beacon Discovery platform, which has been developed to enable researchers to analyse live single cells in real time. Read More

#Videos

#AI / data analytics / healthtech / informatics #Cancer research #Drug discovery #Emulate #Gene expression #Gene therapy #Interview #Metabolomics #Multi-omics #Next generation sequencing #NGS #Omics #Organ-on-a-chip #Personalised medicine #Preclinical investigations #Spatial biology

Podcast: Cutting-edge tools shaping early-stage drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Cutting-edge tools shaping early-stage drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The use-case for NGS”, “Are organ-chips the future of preclinical… Read More

#News

#Drug discovery

Whitepaper – Illuminating Cardiac Risk: Transform Preclinical Drug Safety Testing

VOLTA Scanner is transforming cardiac safety testing. This whitepaper describes an optophysiology instrument, supporting stable, fast, high-resolution toxicity testing and drug development.  Download to learn how: VOLTA detects early-after-depolarizations (EADs), and predicts QT/QRS risk Optogenetic pacing improves assay precision Automated, HPT optophysiological screening streamlines decisions… Read More

#Whitepapers

#Drug discovery

App Note – Unlock More from Your LC/MS

See how Cerno MassWorks™ delivers sub-millidalton mass accuracy and >99% spectral accuracy—enabling formula ID on standard LC/MS systems. This detailed application note walks you through the results, method, and impact. Confidently identify unknowns using spectral accuracy Extend the power of your existing single quad LC/MS Eliminate reliance… Read More

#App Notes

Human heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Last chance: The benefits of 3D cardiac microtissue models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#Drug discovery #Guide #iPSC #Macrophages #Pluripotent stem cells

Guide: Optimising macrophage differentiation from iPSCs

Facing challenges with macrophage differentiation from iPSCs? Discover valuable insights in this new Guide from Lonza: ‘Optimising Macrophage Differentiation from iPSCs with X-VIVO® Media.’ Get the guidance you need to overcome these obstacles to address challenges regularly faced by scientists, from drug discovery to QA/QC. Download the Guide for free… Read More

#News